Key result
Highest ZJU index quartile linked to ~129% higher risk of cardiometabolic multimorbidity.
Why the study?
Does a higher ZJU index predict the development of incident cardiometabolic multimorbidity in middle-aged and older adults?
Cohort (n=6,854)
No
Does a higher ZJU index predict the development of incident cardiometabolic multimorbidity in middle-aged and older adults?
Odds Ratio: 2.29 (95% CI 1.42–3.7)
p-value: p=0.001
The ZJU index is an independent predictor of incident cardiometabolic multimorbidity in middle-aged and older adults, outperforming individual metabolic markers for early risk assessment.
Higher ZJU index was associated with cardiometabolic multimorbidity risk; leaves open its added value for screening beyond standard markers.
OBJECTIVE: This study aimed to comprehensively examine the association between the ZJU index and the risk of developing cardiometabolic multimorbidity (CMM) among middle-aged and older Chinese adults. METHODS: Utilizing data from the Guizhou sub-cohort of the REACTION study, the ZJU index was derived by integrating key metrics, including body mass index (BMI), fasting plasma glucose (FPG), triglycerides (TG), and the alanine aminotransferase to aspartate aminotransferase ratio (ALT/AST). A total of 8,797 participants aged 40 and older were monitored over an average duration of 10.05 years, with 6,854 individuals (77.9%) included in the final analysis. Participants were categorized into quartiles based on their initial ZJU Index levels. To evaluate independent associations, multivariable logistic regression was employed; restricted cubic splines (RCS) were used to illustrate dose-response relationships, and recursive algorithms were applied to determine risk thresholds. The predictive accuracy of the ZJU index was compared with traditional single indicators using receiver operating characteristic (ROC) curves. RESULT: Throughout the follow-up period, 381 new cases of CMM were recorded. After controlling for confounding variables, a linear positive relationship was observed between the ZJU index and CMM risk (P for non-linearity > 0.05). The highest quartile (Q4) exhibited a 2.29-fold increase in the risk of CMM (95% CI: 1.42-3.70) compared to the lowest quartile (Q1). The area under the ROC curve (AUC) for the ZJU index in predicting CMM was 0.651 (95% CI: 0.623-0.678), significantly outperforming the predictive capabilities of BMI, FPG, TG, and the ALT/AST ratio individually. Subgroup analyses revealed that this relationship remained consistent across various categories defined by sex, age, BMI, smoking status, and drinking status, with no significant interactions detected. CONCLUSION: The ZJU index serves as an independent risk factor for CMM. Its straightforward calculation and excellent predictive ability make it highly suitable for early screening and risk assessment in community settings.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) conducted a cohort in Cardiometabolic multimorbidity (CMM) (n=6,854). ZJU index vs. Lowest quartile (Q1) of ZJU index was evaluated on Incident cardiometabolic multimorbidity (CMM) (OR 2.29, 95% CI 1.42-3.70, p=0.001). Middle-aged and older adults in the highest quartile of the ZJU index had a 2.29-fold increased risk of developing cardiometabolic multimorbidity compared to those in the lowest quartile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: